華能國際(600011.SH):江西清能擬出資不超9.24億元與尚華投資共設豐城公司
格隆匯7月27日丨華能國際(600011.SH)公佈,公司全資子公司江西清能於2021年7月27日與尚華投資簽署了《關於成立合資公司的協議》,江西清能將與關聯方尚華投資共同出資設立豐城公司。江西清能將以不超過9.24億元出資,尚華投資將以等值美元出資3.96億元。
交易完成後,江西清能將持有豐城公司70%的權益,尚華投資將持有豐城公司30%的權益。
為提高公司清潔能源裝機佔比,優化產業結構以及滿足豐城市光伏基地項目的開發建設要求,擬成立豐城公司。交易完成後,江西清能將對豐城公司合併報表。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.